The red line of our offering is centered around the patient, providing solutions to utilize the biologic healing capacity of the patient in a broad spectrum of medical specialties and across species.

We pride our self of working with physicians and veterinarians who understand the power of biology and see minimally invasive solutions as the way forward.

The PRF fibrin membrane is manufactured chairside based on venous blood drawn from the patient into PRF tubes. After a few minutes of spin in the centrifuge, a blood clot is turned into a fibrin membrane encapsulating white cells and platelets for slow release for more than 7 days.

The PRF membranes provide the surgeon with access to the patient’s immune system and growth factors concentrated at the surgical site stimulating the processes of the healing cascade in various ways – advancing healing.

Injectable PRF adds an interesting possibility to direct regenerative cells and growth factors into tissues and joints as a fluid. Normally PRF results in a fibrin matrix where the fibrin encapsulates the cells and platelets right after centrifugation. The injectable PRF the clotting is postponed with 10-15 minutes.

myStem® is the leading bedside solution for harvesting and filtering stem cells from adipose tissue in a short time. The myStem® setup utilizes the full lipoaspirate to collect stem cells and regenerative cells. The system allows surgeons to concentrate on the Stromal Vascular Fraction and do injections with a Stem Cell rich fluid component. The solid part of the lipoaspirate can be made into Nanofat. myStem® is flexible and easy to use.

The thinking of placing a concentrate of white cells and platelets with slow release capabilities onto external wounds have shown to be very promising and significantly cheaper than many protocols used today.

The PRF membranes offer a fast and easy to handle approach for external coverage of the wound surface while the injectable PRF provides a new perspective for injection stimulation of the wound edge and thus approach wound healing as a three-dimensional treatment protocol.

By using digital information from a CBCT scan, our partner IBI SA is able to design and manufacture advanced bone structures in the exact shape and size needed. It allows surgeons to do advanced bone reconstruction after trauma or oncology treatments without harvesting bone grafts from the patient. The novel bone graft used is a hybrid of bovine bone and a polymer that gives high stability and slowly is transformed into new bone in the patient.

Human tissue transplants from a donor tissue facility enable surgeons to work less invasive avoiding autologous transplants and donor site morbidity. We represent DIZG who is the largest tissue bank establishment in Germany – Deutsche Institute für Zells- und Gewebeersatz – with a portfolio of more than 250 shapes and sizes. The DIZG portfolio is composed of spongiosa, corticalis, fascia lata, DBM, skin, amnion, and tendons. Products like Epiflex – acellular human dermis – are used in burn wound healing, in breast reconstructions, and as mesh in hernia repair.

The vital elements in any successful wound healing or grafting situation, is the management of the inflammation process, control of fibroblast activity and epithelialization, and the orchestration of neovascularization.

This management task can successfully be performed by using autologous cells collected from sources like the bloodstream, bone marrow, and adipose tissue.

At Puremed our wound healing portfolio is focused on

• Blood-derived cells following the PRF protocol
• Adipose-derived Stem cells, Point-of-Care

Our portfolio of regenerative medicine solutions is today used in the treatment of both small and large animals.

They offer an easy workflow and point of care access to support pain management and wound healing.